These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3958225)

  • 1. Enhanced bioavailability of triazolam following sublingual versus oral administration.
    Scavone JM; Greenblatt DJ; Friedman H; Shader RI
    J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers.
    Fujii J; Inotsume N; Nakano M
    J Pharmacobiodyn; 1988 Mar; 11(3):206-9. PubMed ID: 3411438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.
    Kroboth PD; McAuley JW; Kroboth FJ; Bertz RJ; Smith RB
    J Clin Psychopharmacol; 1995 Aug; 15(4):259-62. PubMed ID: 7593708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.
    Scavone JM; Luna BG; Harmatz JS; von Moltke L; Greenblatt DJ
    Biopharm Drug Dispos; 1990 Apr; 11(3):185-9. PubMed ID: 2328304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sublingually and orally administered triazolam for premedication before oral surgery.
    Berthold CW; Dionne RA; Corey SE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):119-24. PubMed ID: 9269010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
    Tweedy CM; Milgrom P; Kharasch ED; Kaakko T; Spieker M; Coldwell SE
    J Clin Psychopharmacol; 2001 Jun; 21(3):268-72. PubMed ID: 11386489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral formulations of triazolam using radioreceptor assay.
    Lapka R; Cepeláková H; Rejholec V; Franc Z
    Pharmazie; 1986 Apr; 41(4):256-7. PubMed ID: 3725869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolam kinetics: interaction with cimetidine, propranolol, and the combination.
    Friedman H; Greenblatt DJ; Burstein ES; Scavone JM; Harmatz JS; Shader RI
    J Clin Pharmacol; 1988 Mar; 28(3):228-33. PubMed ID: 3360971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive assay for triazolam in plasma following low oral doses.
    Edeki T; Robin DW; Prakash C; Blair IA; Wood AJ
    J Chromatogr; 1992 May; 577(1):190-4. PubMed ID: 1400742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ranitidine on the disposition of orally and intravenously administered triazolam.
    Vanderveen RP; Jirak JL; Peters GR; Cox SR; Bombardt PA
    Clin Pharm; 1991 Jul; 10(7):539-43. PubMed ID: 1860302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.
    Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI
    Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.
    Hukkinen SK; Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):127-31. PubMed ID: 7648762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic noninteraction of triazolam and ethanol.
    Ochs HR; Greenblatt DJ; Arendt RM; Hübbel W; Shader RI
    J Clin Psychopharmacol; 1984 Apr; 4(2):106-7. PubMed ID: 6142906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
    Lui CY; Amidon GL; Goldberg A
    J Pharm Sci; 1991 Dec; 80(12):1125-9. PubMed ID: 1815070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.